Liminatus Pharma, Inc. · NASDAQ:LIMN
Valetudo Therapeutics LLC reported a 14.30% stake in Liminatus Pharma, Inc. (Schedule 13D/A)
Event Jul 2, 2026 · Filed Jul 14, 2026
Valetudo Therapeutics LLC reported a 14.30% stake in Liminatus Pharma, Inc., 9,617,954 shares, with active intent on Jul 2, 2026. Filed Jul 14, 2026 (Schedule 13D/A).
- Stake
- 14.30%
- Shares
- 9,617,954
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Valetudo Therapeutics LLC | 14.30% | 9,617,954 |
| Chris Kim | 14.30% | 9,617,954 |
Source
Related
- Liminatus Pharma, Inc.
- Valetudo Therapeutics LLC
- Liminatus Pharma, Inc. shareholders
- Schedule 13D · Valetudo Therapeutics LLC · May 7, 2025
- Schedule 13G · Samda Biolab Co., Ltd. · Jul 22, 2026
- Form 4 · Valetudo Therapeutics LLC · Jul 14, 2026
- Form 4 · Valetudo Therapeutics LLC · Jul 6, 2026
- Schedule 13G/A · Ewon Comfortech Co., Ltd. · Jul 6, 2026
- Schedule 13G · Mitchell P. Kopin · Feb 20, 2026